Back to 
Deutsche Bank AG
Deutsche Bank AG
HBIO
Showing 4 of 23 quarters
Position history for Deutsche Bank AG's holdings in Harvard Bioscience, Inc.
No. Deutsche Bank exited its HBIO (Harvard Bioscience) position in Q2 2025. Its Q1 2025 13F listed 75,985 shares worth $43,312. Deutsche Bank already held HBIO in its Q4 2018 13F, the earliest on record, and held it in 20 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$63,661
Total Shares Change
-23,666
Quarter-by-Quarter History